recombinant human interleukin-12
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human interleukin-12, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants [Phase 1]